Sequenom and Ariosa are the two parties named in the NYT article in the previous post. As usual, it is not that simple. There are several parties on both sides and a lot of cross suing going on. But my research has revealed one of the patents (there may be more) involved in the case. USPN
"Non-invasive prenatal diagnosis."
Talk about ethics! This one's a beaut.
Here's a link to the patent: